Search

everythinglearnresearchcommunity

for

Search:↓

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Medications for PCOS don't seem to raise heart disease risk.

FGF-2&D/P nanoparticles can help treat hair loss.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

New compounds may help treat prostate issues without affecting androgen receptors.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Finasteride may worsen blood sugar control in diabetic patients.

Pexidartinib often causes liver issues and fatigue, especially in women.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

GD-23 reduces anxiety by relying on neurosteroid production.

A patient developed a blister at the injection site after hepatitis C treatment.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

The new compound may be a safer alternative to finasteride for prostate protection.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Dutasteride is approved to help manage prostate enlargement.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.